One notable example is the R-CHOP regimen used for treating non-Hodgkin lymphoma, which combines rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone. Another example is the combination of trastuzumab with chemotherapy for HER2-positive breast cancer. In lung cancer, a combination of immunotherapy with platinum-based chemotherapy has shown promising results.
